-0.005 (-0.658%)Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Cyclopharm Limited
Telephone
61.2.9541.0411
Address
Unit 4, 1 The Crescent, Kingsgrove, New South Wales (NSW) 2208
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.56 - 1.29
Trade Value (12mth)
AU$17,665.00
1 week
-5.59%
1 month
1.33%
YTD
-22.84%
1 year
-33.91%
All time high
3.45
EPS 3 yr Growth
118.10%
EBITDA Margin
-50.80%
Operating Cashflow
-$17m
Free Cash Flow Return
-40.90%
ROIC
-40.70%
Interest Coverage
-26.20
Quick Ratio
1.50
Shares Outstanding (Fully Diluted)
111m
HALO Sector
Healthcare
Next Company Report Date
24-Feb-27
Next Ex Dividend Date
01-Sep-23
Next Dividend Pay Date
11-Sep-23
Reporting Currency
AUD
Short Sell (% of issue)
0.01
| Date | Announcements |
| 08 May 26 | |
| 08 May 26 | |
| 08 May 26 | |
| 08 May 26 | |
| 08 May 26 |
Historical data
Forecast data
| AUD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.05 | -0.13 | -0.16 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.05 | -0.13 | -0.16 | | | | ||
Growth | % | | | | | 29.3 | -152.9 | -22 | | | | ||
PE | X | | | | | N/A | N/A | 190 | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Months Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
